Brendan Maughan-Brown

Chief Research Officer

Research Interests

  • Uptake of HIV prevention and treatment services
  • Behavioural economics
  • The social and behavioural determinants of HIV risk
  • Vaccine hesitancy

Biography

Dr Brendan Maughan-Brown is an interdisciplinary social scientist with expertise on the uptake of HIV-prevention and treatment services; behavioural economics; the social and behavioural determinants of HIV risk; COVID-19 preventive behaviours and vaccine hesitancy; and survey design. Dr. Maughan-Brown serves as a Chief Research Officer at the Southern Africa Labour and Development Research Unit, University of Cape Town. He is a faculty member for Indlela – a behavioural nudge unit based at the University of Witwatersrand’s Health Economics and Epidemiology Research Office (HE2RO). Brendan’s research interests include behavioural interventions to increase demand for health services and products, including COVID-19 vaccines; understanding high HIV incidence rates among young women in Africa; HIV testing; linkage to HIV care; and HIV stigma. Brendan holds a PhD in Economics from the University of Cape Town.

 Brendan Maughan-Brown's CV

Recent Publications 

  • Mistri P, Tomescu S, Bokolo S, De Nooy A, Pisa P, Grove S, Schmucker L, Chetty-Makkan C, Long L, Buttenheim A, Maughan-Brown B. Evaluation of four interventions using behavioural economics insights to increase demand for voluntary medical male circumcision in South Africa through the MoyaApp: A quasi-experimental study. Journal of Acquired Immune Deficiency Syndromes. In press.

  • Eyal K, Njozela L, Köhler T, Ingle K, Brophy T, Buttenheim AM, Maughan-Brown B. Correlates of COVID-19 Vaccination Intentions and opinions about mandates among four groups of adults in South Africa with distinct vaccine intentions: Evidence from a large national survey. BMC Public Health. 2023;23: 1767

  • Maughan-Brown B, Eyal K, Njozela L, Buttenheim AM. Predictors of COVID-19 vaccine uptake among adults in South Africa: Multi-method evidence from a population-based longitudinal study. BMJ Global Health. 2023;8(8):e012433.